Drugmaker CEO Cleared After Former Executive Alleged Bullying
This article is for subscribers only.
A generic-drug company’s board cleared its leader of inappropriate conduct after a former top executive alleged abusive, bullying behavior by the chief executive.
In a statement dated March 16, Iceland-based Alvogen Group’s board said there was no basis for concerns about the management style of Executive Chairman and Chief Executive Officer Robert Wessman, and that no corrective action was needed. The review followed allegations from Halldor Kristmannsson, Alvogen’s former vice president of global corporate marketing, of abusive, bullying behavior by Wessman over a period of years.